Briton researchers have found a simple placebo may really work well to cure insomnia.
The findings, appeared in journal Brain, indicated that both neurofeedback and placebo-feedback to be equally effective as reflected in subjective measures of sleep complaints, which suggests that the observed improvements were due to unspecific factors such as - experiencing trust and receiving care and empathy from experimenters.
On this note, placebo is a substance or treatment with no active therapeutic effect. A placebo may be given to a person in order to deceive the recipient into thinking that it is an active treatment.
The team from Oxford University recruited 30 patients with primary insomnia, who underwent neurofeedback treatment and placebo-feedback treatment over several weeks.
They sought to test whether earlier findings on the positive effect of neurofeedback, on sleep quality and memory could also be replicated in a double-blind placebo-controlled study.
The patients spent nine nights and twelve sessions of neurofeedback and twelve sessions of placebo-feedback training.
Insomnia patients underwent this procedure before and after real as well as placebo neurofeedback training.
In between the first and second, as well as the third and fourth of these visits, insomnia patients completed twelve sessions of neurofeedback treatment and twelve sessions of placebo-feedback treatment.
The order of trainings, that is, real or placebo neurofeedback treatment was counterbalanced across the participants and the twelve sessions were completed within four weeks.
The participants' sleep-wake cycle was assessed using eight sleep laboratory nights, as well as sleep diaries and actigraphy over the course of the whole protocol.
They did not find an advantage of neurofeedback over placebo-feedback.
"Given our results," said lead author Manuel Schabus, "one has to question how much of published neurofeeback effects are due to simple expectations on the side of the participants or, in other words, unspecific placebo effects".
The study found that improvement of symptoms was not specific to neurofeeback training, but rather seems to have been brought about by unspecific factors such as affection and care.
Especially in patient populations where various complaints are often associated with learning difficulties positive neurofeedback effects beyond the subjective level may be hard to achieve.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
